Bri-Chem (BRY) Q2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2023 earnings summary
22 Oct, 2026Executive summary
Q2 sales were $25.2M, down $240K YoY; adjusted EBITDA rose $190K to $2.0M, while operating earnings fell 28% to $1.2M.
H1 sales increased 7% to $52.4M; adjusted EBITDA declined 15% to $3.6M and adjusted net earnings fell 57% to $1.1M.
Financial highlights
Q2 net earnings were $553K, up 62% YoY; adjusted net earnings were $714K, down 19%.
H1 net earnings were $818K versus $8.1M YoY; adjusted net earnings were $1.1M versus $2.6M.
Q2 adjusted EBITDA was $1.972M versus $1.782M YoY; as a share of revenue, it improved to 8% from 7%.
Outlook and guidance
Oil and gas activity showed signs of stabilization, expected to continue through year-end; stable WTI and rig counts may support regional growth in Texas and Oklahoma.
Depressed natural gas prices cloud near-term activity; pricing adjustments and lower-cost sourcing are intended to improve margins.
Growth opportunities at the Midland, Texas facility are expected to materialize over the next 6–12 months.
Maintaining a low-cost overhead structure is a priority to remain prepared for rapid changes in activity.
Latest events from Bri-Chem
- Sales grew 16%, but higher costs and lower margins cut adjusted EBITDA 34%.BRY
Q1 2023 - Q4 adjusted EBITDA rose 35%, while FY operating earnings fell 40%.BRY
Q4 2023 - Lower U.S. rig activity and margin pressure cut Q3 earnings; a modest 2024 recovery is possible.BRY
Q3 2023 - Lower US drilling drove a 24% sales decline and Q2 net loss.BRY
Q2 2024 - Lower drilling activity drove a 21% sales decline and a $443K Adjusted EBITDA loss.BRY
Q1 2024 - Weaker US drilling drove lower Q3 sales, earnings and Adjusted EBITDA.BRY
Q3 2024 - Lower sales and a $1.1M bad-debt write-off drove FY adjusted EBITDA negative.BRY
Q4 2024 - Lower US drilling cut sales 7%, while adjusted EBITDA returned to positive territory.BRY
Q1 2025 - Q2 earnings improved as sales rose, but Canadian demand remains soft.BRY
Q2 2025